Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)piperazine
2. Aphilan
3. Bucladin-s
4. Buclizine
5. Buclizine Hydrochloride
6. Softran
1. 129-74-8
2. Buclizine Hydrochloride
3. Longifene
4. Buclizine Hcl
5. Buclina
6. Softran
7. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine Dihydrochloride
8. Buclizine, Dihydrochloride
9. Bucladin-s
10. Aphilan
11. Buclodin
12. Ucb 4445
13. Aphilan R
14. Bucladin
15. Buclizine Hydrochloride [usan]
16. Vibazine Hydrochloride
17. Ucb-4445
18. Vibazine
19. Histabutyzine Hydrochloride
20. Histabutyzine Dihydrochloride
21. Buclizine (dihydrochloride)
22. Eop5593fph
23. V4oce982yu
24. 58fqd093nu
25. Buclizine Hydrochloride, (+)-
26. Buclizine Hydrochloride, (-)-
27. Chebi:61193
28. 1-(p-chlorobenzhydryl)-4-(p-t-butylbenzyl)diethylenediamine Dihydrochloride
29. 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)piperazine Dihydrochloride
30. 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine;dihydrochloride
31. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride
32. Postafeno
33. A 7668
34. Bucladin S
35. Nsc-25141
36. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)-(phenyl)methyl)piperazine Dihydrochloride
37. Buclizine Hydrochloride (usan)
38. 1-(p-tert-butylbenzyl)-4-(p-chlorodiphenylmethyl)piperazine Dihydrochloride
39. Buclizine 2hcl
40. 163837-35-2
41. 163837-36-3
42. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride, (+)-
43. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Dihydrochloride, (-)-
44. Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, Hydrochloride (1:2)
45. Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-, Dihydrochloride
46. Einecs 204-962-4
47. Nsc 25141
48. Unii-58fqd093nu
49. Vibazine (tn)
50. 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)piperazine Dihydrochloride
51. 1-p-chlorobenzhydryl-4-p-(t)-butylbenzylpiperazine Dihydrochloride
52. Unii-eop5593fph
53. Unii-v4oce982yu
54. Dsstox_cid_25091
55. Dsstox_rid_80665
56. Dsstox_gsid_45091
57. Schembl123751
58. Chembl2360580
59. Dtxsid5045091
60. Perlapine, >=98% (hplc)
61. Hy-a0128a
62. Bcp22428
63. Tox21_110023
64. Mfcd00242700
65. S4140
66. Buclizine Dihydrochloride [mi]
67. 5-isopropyl-2-methoxyphenylboronicacid
68. Akos016004771
69. Bcp9000459
70. Buclizine Hydrochloride [mart.]
71. Buclizine Hydrochloride [vandf]
72. Ks-1250
73. Buclizine Hydrochloride [who-dd]
74. Piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-alpha-phenylbenzyl)-, Dihydrochloride
75. Ncgc00013315-01
76. Ac-32891
77. Cas-129-74-8
78. Bcp0726000050
79. Buclizine Dihydrochloride, >=98% (hplc)
80. Buclizine Hydrochloride [orange Book]
81. Cs-0019690
82. Ft-0663892
83. D02089
84. 129b748
85. J-005711
86. Q27130875
87. (rs)-1-(4-t-butylbenzyl)-4-(4-chlorobenzhydryl) Piperazine Dihydrochloride
88. 1-(4-(tert-butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazinedihydrochloride
89. 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine Dihydrochloride
90. 1-(4-tert-butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazinediium Dichloride
91. 7139-55-1
| Molecular Weight | 505.9 g/mol |
|---|---|
| Molecular Formula | C28H35Cl3N2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 504.186582 g/mol |
| Monoisotopic Mass | 504.186582 g/mol |
| Topological Polar Surface Area | 6.5 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 514 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3874
Submission : 1980-06-27
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Date of Issue : 2022-08-16
Valid Till : 2025-08-13
Written Confirmation Number : WC-0229
Address of the Firm : Survey No. 270, Nawabpet Village, Shivampet Mandai, Medak District, Telangana-50...
Date of Issue : 2020-06-18
Valid Till : 2022-08-13
Written Confirmation Number : WC-0229A2
Address of the Firm : Survey No.270, Nawabpet (V), Shivampet (M), Medak District, Telangana State, Ind...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
About the Company : With 33 years of CONSISTENCY, CREDIBILITY & CONTINUITY, D K Pharma has established its presence in the Global Market for Manufacturing Bulk Drugs, Speciality Fine Chemicals and Adv...
About the Company : Fleming Laboratories Limited is in the business of manufacturing and supply of high-quality generic Active Pharmaceutical Ingredients (APIs) to the global Pharmaceutical Industry. ...
About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...
About the Company : RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor si...
About the Company : Srikem is a trusted source of Active Pharmaceutical Ingredients (APIs) for top pharmaceutical companies around the world. The company was founded in the year 1994 and our founder M...
About the Company : Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build ar...
About the Company : Zeal Medipharma is a Star-rated Export House serving customers in over 50 countries for more than two decades. The company specializes in sourcing and exporting APIs for human and ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
51
PharmaCompass offers a list of Buclizine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Buclizine Hydrochloride manufacturer or Buclizine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Buclizine Hydrochloride manufacturer or Buclizine Hydrochloride supplier.
A buclizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of buclizine, including repackagers and relabelers. The FDA regulates buclizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. buclizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of buclizine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A buclizine supplier is an individual or a company that provides buclizine active pharmaceutical ingredient (API) or buclizine finished formulations upon request. The buclizine suppliers may include buclizine API manufacturers, exporters, distributors and traders.
click here to find a list of buclizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A buclizine DMF (Drug Master File) is a document detailing the whole manufacturing process of buclizine active pharmaceutical ingredient (API) in detail. Different forms of buclizine DMFs exist exist since differing nations have different regulations, such as buclizine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A buclizine DMF submitted to regulatory agencies in the US is known as a USDMF. buclizine USDMF includes data on buclizine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The buclizine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of buclizine suppliers with USDMF on PharmaCompass.
A buclizine written confirmation (buclizine WC) is an official document issued by a regulatory agency to a buclizine manufacturer, verifying that the manufacturing facility of a buclizine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting buclizine APIs or buclizine finished pharmaceutical products to another nation, regulatory agencies frequently require a buclizine WC (written confirmation) as part of the regulatory process.
click here to find a list of buclizine suppliers with Written Confirmation (WC) on PharmaCompass.
buclizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of buclizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right buclizine GMP manufacturer or buclizine GMP API supplier for your needs.
A buclizine CoA (Certificate of Analysis) is a formal document that attests to buclizine's compliance with buclizine specifications and serves as a tool for batch-level quality control.
buclizine CoA mostly includes findings from lab analyses of a specific batch. For each buclizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
buclizine may be tested according to a variety of international standards, such as European Pharmacopoeia (buclizine EP), buclizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (buclizine USP).
